BRD4 Short Isoform Interacts with RRP1B, SIPA1 and Components of the LINC Complex at the Inner Face of the Nuclear Membrane
Open Access
- 19 November 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (11), e80746
- https://doi.org/10.1371/journal.pone.0080746
Abstract
Recent studies suggest that BET inhibitors are effective anti-cancer therapeutics. Here we show that BET inhibitors are effective against murine primary mammary tumors, but not pulmonary metastases. BRD4, a target of BET inhibitors, encodes two isoforms with opposite effects on tumor progression. To gain insights into why BET inhibition was ineffective against metastases the pro-metastatic short isoform of BRD4 was characterized using mass spectrometry and cellular fractionation. Our data show that the pro-metastatic short isoform interacts with the LINC complex and the metastasis-associated proteins RRP1B and SIPA1 at the inner face of the nuclear membrane. Furthermore, histone binding arrays revealed that the short isoform has a broader acetylated histone binding pattern relative to the long isoform. These differential biochemical and nuclear localization properties revealed in our study provide novel insights into the opposing roles of BRD4 isoforms in metastatic breast cancer progression.Keywords
This publication has 58 references indexed in Scilit:
- The LINC-anchored actin cap connects the extracellular milieu to the nucleus for ultrafast mechanotransductionScientific Reports, 2013
- MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunitsNature, 2012
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain FamilyCell, 2012
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaNature, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- Chemical probes for histone-modifying enzymesNature Chemical Biology, 2008
- The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survivalClinical & Experimental Metastasis, 2008
- Successful co-immunoprecipitation of Oct4 and Nanog using cross-linkingBiochemical and Biophysical Research Communications, 2007